One-third of trans people taking testosterone may still ovulate, raising chance of pregnancy

In a small study of transgender men and gender-diverse people who take testosterone, scientists found that one-third of the participants still ovulate and could therefore potentially become pregnant.

Close-up picture of a blue and white box of AndroGel, aka testosterone gel, containing individual packets of the gel
The new study revealed that a third of transmasculine people taking testosterone may still ovulate even if their periods have stopped as a result of the gender-affirming hormone therapy.
(Image credit: Bloomberg / Contributor via Getty Images)

Many transgender men and other gender-diverse people opt to take testosterone to bring about male secondary sex characteristics, such as a deeper voice and thicker body and facial hair, and to suppress female characteristics, such as menstruation. While taking this hormone therapy, a person may no longer get their period, however, they may still ovulate and therefore could potentially get pregnant, a new study finds.

The small study included 52 transmasculine people, meaning people who were assigned female at birth but whose gender identity aligns with masculinity; this term can include transgender men and some nonbinary and gender-fluid people, for instance. 

Emily Cooke
Staff Writer

Emily is a health news writer based in London, United Kingdom. She holds a bachelor's degree in biology from Durham University and a master's degree in clinical and therapeutic neuroscience from Oxford University. She has worked in science communication, medical writing and as a local news reporter while undertaking NCTJ journalism training with News Associates. In 2018, she was named one of MHP Communications' 30 journalists to watch under 30.